MVM Life Science Partners: €20M-€100M checks, Seed to Growth

Check size
€20M – €100M

Investment focus

Investment thesis

Global healthcare VC. $700M+ across 4 funds. Invests in biopharma, medtech, and digital health from seed to late stage. Aggregate $20-100M per company over holding period.

How to Pitch MVM Life Science Partners

No stated policy
MVM Life Science Partners hasn't published an outreach policy. A short, specific cold email is the safest default.

Who to contact

Addison Van Emon
Arantza Rodriguez

Portfolio highlights

GT Medical Technologies
GammaTile
Neurent Medical
Proverum
Nalu Medical
Avanzanite

Partners

Auto-detected from MVM Life Science Partners's website.

Addison Van Emon
Checked Oct 2026
Arantza Rodriguez
Checked Oct 2026
Chris Murray
Checked Oct 2026
Conrad Crans
Checked Oct 2026
Eric Bednarski
Checked Oct 2026
Eric Fritz
Checked Oct 2026
Hugo Harrod
Checked Oct 2026
Isabella Mihov
Checked Oct 2026
Jack Tanaka
Checked Oct 2026
Kevin Cheng
Checked Oct 2026
Kyle Dempsey
Checked Oct 2026
Liz Butler
Checked Oct 2026
Neil Akhurst
Checked Oct 2026
Orlanda Bryars
Checked Oct 2026
Shalima Raza
Checked Oct 2026
Stephen Reeders
Checked Oct 2026
Talia Kirschbaum
Checked Oct 2026
Thangam Jayaram
Checked Oct 2026
Thomas Casdagli
Checked Oct 2026

Focus and check size from the firm's website. Website reachable as of Nov 2026.

Ready to reach MVM Life Science Partners?

Red-pen your deck first so the gaps are fixed before they read it. A fit check then scores your pitch against their thesis, stage and ticket, and an email draft uses their real deals and thesis, not a template.

Contact

mvm.com

Reach MVM Life Science Partners through the links above. Pitchkit is not affiliated with the firm and does not forward pitches.